Many efforts to develop vaccines and therapies to thwart SARS-CoV-2 focus on the coronavirus spike protein, which binds the angiotensin-converting enzyme 2 (ACE2) on human cells to allow viral entry. Now, researchers have uncovered an active role for glycans — sugar molecules that can decorate proteins — in this process, suggesting targets for vaccines and therapies.
Click here for original story, Glycans in the SARS-CoV-2 spike protein play active role in infection
Source: ScienceDaily